Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)
3-D PET/CT in situ detection of gastric tumors in mouse stomachs. Signals from 18F-FDG uptake in fasudil-treated (4 weeks) and control mice presented as graded color code with standard uptake value (SUVbw) range of 0.5-10. (Tu = tumor, bl =bladder). Arrows show the gastric tumor between the two kidneys and below the heart
PET/CT images of MDA-MB-231 tumor xenografts in mice 24 hours after intravenous injection with 64Cu-anti-hAXL. Treatment group received daily 17-AAG injections and showed lower tumor uptake of 64Cu-anti-hAXL than the vehicle-treated control group.

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to determine the efficacy of potential novel treatments.

September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated decision support tool for echocardiography.

September 13, 2021 — At the opening press conference of the ESMO Congress 2021, President Solange Peters announced that ESMO, the leading professional society for medical oncology, is launching the International Cancer Foundation, ICF by its acronym, which has taken upon itself a mission to support activities that enhance cancer prevention, diagnosis, treatment and follow-up in every country where

September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exhibition planned for RSNA’s 

September 10, 2021 — Ikonopedia announced that it has added Banner Health, one of the largest non-profit health care systems in the country, as a customer and will implement its entire suite of structured breast imaging reporting and MQSA management tools.

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and 

September 10, 2021 — New recommendations will help provide more reliable, reproducible results for magnetic resonance imaging (MRI)-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal 

September 9, 2021 — Agfa HealthCare is proud to be one of the first companies to receive the new European Medical Device Regulation (MDR) certification, which was issued by Intertek on August 25, 2021.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now